✦ LIBER ✦

Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency

✍ Scribed by Anne Marie Comeau; Jaime E. Hale; Sung-Yun Pai; Francisco A. Bonilla; Luigi D. Notarangelo; Mark S. Pasternack; H. Cody Meissner; Ellen Rae Cooper; Alfred DeMaria; Inderneel Sahai; Roger B. Eaton

Publisher: Springer
Year: 2010
Tongue: English
Weight: 169 KB
Volume: 33
Category: Article
ISSN: 0141-8955
DOI: 10.1007/s10545-010-9103-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Newborn Screening for Severe Combined Im

Newborn Screening for Severe Combined Immunodeficiency; The Wisconsin Experience (2008–2011)

✍ James W. Verbsky; Mei W. Baker; William J. Grossman; Mary Hintermeyer; Trivikram 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 209 KB

Establishing treatment benchmarks for ma

Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines

✍ Geoff Delaney; Jesmin Shafiq; Genevieve Chappell; Michael Barton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract ## BACKGROUND. No benchmarks exist in the screened breast cancer population to establish the optimal proportions of newly detected cancer patients who should receive the ideal treatment. The aim of the study was to estimate the optimal proportion of cases diagnosed in a breast‐screenin

Ultrasound screening for developmental d

Ultrasound screening for developmental dysplasia of the hip in the newborn: a population-based study in the Maribor region, 1997–2005

✍ Milena Treiber; Tomaž Tomažič; Andreja Tekauc-Golob; Jože Žolger; Bojan Korpar; 📂 Article 📅 2008 🏛 Springer Vienna 🌐 English ⚖ 151 KB

POBASCAM, a population-based randomized

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women

✍ Nicole W.J. Bulkmans; Lawrence Rozendaal; Peter J.F. Snijders; Feja J. Voorhorst 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 253 KB 👁 2 views

## Abstract Cytological cervical screening is rather inefficient because of relatively high proportions of false negative and false positive smears. To evaluate the efficiency of high‐risk human papillomavirus (hrHPV) testing, by GP5+/6+ PCR‐enzyme immunoassay (EIA), in conjunction with cytology (I